KLH conjugated synthetic peptide derived from human CDKN2D/p19 INK4d: 65-166/166
Conjugate
Unconjugated
Applications
Application Notes
ELISA: 1:5000-10000
General Notes
This product (Catalog No. DPABH-03401) is a rabbit-derived IgG polyclonal antibody raised against human CDKN2D, targeting the amino acid region 65–166 of the protein. This antibody exhibits cross-reactivity with CDKN2D from mouse and rat. It has been affinity purified by Protein A. The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to form a stable complex with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. The abundance of the transcript of this gene was found to oscillate in a cell-cycle dependent manner with the lowest expression at mid G1 and a maximal expression during S phase. The negative regulation of the cell cycle involved in this protein was shown to participate in repressing neuronal proliferation, as well as spermatogenesis. Two alternatively spliced variants of this gene, which encode an identical protein, have been reported. DPABH-03401 is suitable for use in ELISA (1:5,000–1:10,000) application. DPABH-03401 is supplied as a liquid formulation in 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human CDKN2D (a.a. 65-166) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.